102 related articles for article (PubMed ID: 9722729)
21. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling.
Tatebe S; Ishida M; Kasagi N; Tsujitani S; Kaibara N; Ito H
Int J Cancer; 1996 Jan; 65(2):173-7. PubMed ID: 8567113
[TBL] [Abstract][Full Text] [Related]
22. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma.
Pastushenko I; Van den Eynden GG; Vicente-Arregui S; Prieto-Torres L; Alvarez-Alegret R; Querol I; Dirix LY; Carapeto FJ; Vermeulen PB; Van Laere SJ
Am J Dermatopathol; 2016 May; 38(5):338-46. PubMed ID: 26909582
[TBL] [Abstract][Full Text] [Related]
23. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.
Luzzi KJ; MacDonald IC; Schmidt EE; Kerkvliet N; Morris VL; Chambers AF; Groom AC
Am J Pathol; 1998 Sep; 153(3):865-73. PubMed ID: 9736035
[TBL] [Abstract][Full Text] [Related]
24. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
25. Influence of tumor thickness and vascularity on survival in cutaneous melanoma.
Zamolo G; Gruber F; Cabrijan L; Micović V; Iternicka Z; Jonjić N
Acta Med Okayama; 2001 Oct; 55(5):289-93. PubMed ID: 11688952
[TBL] [Abstract][Full Text] [Related]
26. The vascularity of primary cutaneous melanoma.
Fallowfield ME; Cook MG
J Pathol; 1991 Jul; 164(3):241-4. PubMed ID: 1890549
[TBL] [Abstract][Full Text] [Related]
27. Vascular retardation in dormant growth-stunted malignant melanomas.
Piérard-Franchimont C; Henry F; Heymans O; Piérard GE
Int J Mol Med; 1999 Oct; 4(4):403-6. PubMed ID: 10493982
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
[TBL] [Abstract][Full Text] [Related]
29. Assessment of proliferation markers in metastatic melanoma in sentinel lymph nodes.
Joannou-Coetzee A; Villena N; Powell BW; Cook MG
J Clin Pathol; 2011 Dec; 64(12):1108-11. PubMed ID: 21896579
[TBL] [Abstract][Full Text] [Related]
30. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.
Kashani-Sabet M; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR
J Clin Oncol; 2002 Apr; 20(7):1826-31. PubMed ID: 11919240
[TBL] [Abstract][Full Text] [Related]
31. Extensive apoptosis in ductal carcinoma in situ of the breast.
Bodis S; Siziopikou KP; Schnitt SJ; Harris JR; Fisher DE
Cancer; 1996 May; 77(9):1831-5. PubMed ID: 8646681
[TBL] [Abstract][Full Text] [Related]
32. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay.
Rongioletti F; Miracco C; Gambini C; Pastorino A; Tosi P; Rebora A
Am J Dermatopathol; 1996 Oct; 18(5):474-7. PubMed ID: 8902093
[TBL] [Abstract][Full Text] [Related]
33. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour.
Srivastava A; Hughes LE; Woodcock JP; Laidler P
Br J Cancer; 1989 Jan; 59(1):89-91. PubMed ID: 2667611
[TBL] [Abstract][Full Text] [Related]
34. Therapy of hematogenous melanoma brain metastases with endostatin.
Kirsch M; Weigel P; Pinzer T; Carroll RS; Black PM; Schackert HK; Schackert G
Clin Cancer Res; 2005 Feb; 11(3):1259-67. PubMed ID: 15709197
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen.
Guffey JM; Chaney JV; Stevens GL; Schroer KR; Fenske NA; Reintgen D; Glass LF
J Cutan Pathol; 1995 Apr; 22(2):122-7. PubMed ID: 7560343
[TBL] [Abstract][Full Text] [Related]
36. [Influence of growth rates of local recurrences and in-transit metastases on survival of patients with cutaneous melanoma].
Mikhnin AE; Barchuk AS; Wagner RI; Anisimov VV
Vopr Onkol; 2004; 50(5):557-61. PubMed ID: 15715096
[TBL] [Abstract][Full Text] [Related]
37. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
[TBL] [Abstract][Full Text] [Related]
38. Melanoma prognostic factors found in the dermatopathology report.
Payette MJ; Katz M; Grant-Kels JM
Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154
[TBL] [Abstract][Full Text] [Related]
39. Thrombospondin-1 treatment prevents growth of dormant lung micrometastases after surgical resection and curative radiation therapy of the primary tumor in human melanoma xenografts.
Rofstad EK; Galappathi K; Mathiesen B
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):493-9. PubMed ID: 14751520
[TBL] [Abstract][Full Text] [Related]
40. Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos.
Goldberg JL; Zanella CL; Janssen YM; Timblin CR; Jimenez LA; Vacek P; Taatjes DJ; Mossman BT
Am J Respir Cell Mol Biol; 1997 Sep; 17(3):265-71. PubMed ID: 9308911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
